CHANGE OF THE NUMBER OF SHARES AND VOTES IN KARO BIO

STOCKHOLM, November 4, 2015 - Karo Bio AB (publ) today announced that the
company’s total number of shares as per October 31, 2015 amounted to 49 544 121
shares, corresponding to an equal number of votes. The increase in the number of
shares and votes results from the recently completed acquisition of 100% of the
shares in Swereco Group and the directed new share issue of 2 551 218 shares to
the shareholders in Swereco Group.

FOR FURTHER INFORMATION PLEASE CONTACT:
Henrik Palm, CFO, phone 070-540 40 14 or e-mail henrik.palm@karobio.se

ABOUT KARO BIO
Karo Bio is a healthcare company that develops and markets products to
pharmacies and directly to healthcare providers. The share is listed on Nasdaq
Stockholm.

The information in this report is such that Karo Bio is required to disclose
under the Swedish Securities Market Act. The information was disclosed on
November 4, 2015 at 7.15 p.m. CET.

This press release is also available on www.karobio.se and
www.newsroom.cision.com .